EMPOWER AUD Pivotal Trial

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 6, 2025

Study Completion Date

August 6, 2025

Conditions
AlcoholismAlcohol AbuseAlcohol Use Disorder
Interventions
DEVICE

Empower Neuromodulation System

The Empower Neuromodulation System is designed to provide transcutaneous stimulation to the branches of a spinal nerve. The system comprised of three key components: (A) The Stimulator, (B) the Empower smartphone app, and (C) the Gel Patch. The smartphone application is used to coordinate treatment and record participant responses.

Trial Locations (2)

94143

University of California, San Francisco, San Francisco

06516

Yale University, New Haven

All Listed Sponsors
lead

Theranova, L.L.C.

INDUSTRY

NCT05948605 - EMPOWER AUD Pivotal Trial | Biotech Hunter | Biotech Hunter